Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,583.63 -73.45 -0.85%
TOPIX 720.05 -6.98 -0.96%
Hang Seng 18,897.10 -158.34 -0.83%
Gold 1,553.60 +0.17%
EUR-USD 1.2467 -0.2861%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.39 -0.41%
U.S. 10-year 1.724% -0.014
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: New York
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

Medtronic Inc

Add to Portfolio

MDT:US

37.2800 USD 0.4000 1.08%

As of 20:04:03 ET on 05/29/2012.

Snapshot for Medtronic Inc (MDT)

Open: 37.0300 Day's Range: 36.9700 - 37.3294 Volume: 3,758,869 Bid: 37.3100
Previous Close: 36.8800 52wk Range: 30.1800 - 40.8100 1-Yr Rtn: -5.05% Ask: 37.2800

Stock Chart for MDT

No chart data available.
  • MDT:US 37.2800
  • 1D
  • 1M
  • 1Y
36.8800
Interactive MDT Chart

Previous Close

Key Statistics for MDT

Current P/E Ratio (ttm) 11.1952
Estimated P/E (04/2013) 10.2025
Earnings Per Share (USD) (ttm) 3.3300
Est. EPS (USD) (04/2013) 3.6540
Est. PEG Ratio 1.4348
Market Cap (M USD) 38,666.63
Shares Outstanding (M) 1,037.20
Enterprise Value (M USD) (ttm) 46,541.63
Enterprise Value/EBITDA (ttm) 7.64
Price/Book (mrq) 2.2595
Price/Sale (ttm) 2.3972
Dividend Indicated Gross Yield 2.5998
Next Earnings Announcement 08/23/2012
More MDT Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for MDT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More MDT Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More MDT Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More MDT Cash Flow Data

Company Profile & Key Executives for MDT

Medtronic, Inc. develops therapeutic and diagnostic medical products. The Company's principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders. Medtronic's products are sold worldwide.

Omar S IshrakChairman/CEOGary L EllisSenior VP/CFO
Donald Cameron FindlaySenior VP/Secy/Gen Cnsl
More Company Profile & Key Executives for MDT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements